Approval success rates of drug candidates based on target, action, modality, application, and their combinations
Abstract The current success rate of a drug candidate, from the beginning of the clinical trial to receiving marketing approval, is about 10%-20%, and it has not changed during the past few decades. Therefore, pharmaceutical companies are under pressure to select one compound, among many others, wit...
Saved in:
Main Authors: | Shingo Yamaguchi (Author), Masayuki Kaneko (Author), Mamoru Narukawa (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Refractory Candidal Granuloma by Itraconazole and Terbinafine in Combination with Hyperthermia and Cryotherapy
by: Heli Yang, et al.
Published: (2020) -
Successful generic drug product development: From research to marketing approval
by: Suchart Chongprasert
Published: (2016) -
2020 FDA/EMA approvals for new immunotherapy drug technologies and applications
by: Maryam Monajati, et al.
Published: (2021) -
The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma
by: article Editorial
Published: (2023) -
Adverse events of targeted therapies approved for women's cancers
by: Mathilde Saint-Ghislain, MD, et al.
Published: (2021)